Mercury General (MCY)’s Insider Joshua Little Obtained 500 Shares of the Company; Radius Health (RDUS)’s Sentiment Is 1.37

Radius Health, Inc., a biopharmaceutical company, develops and sells therapeutics in the areas of osteoporosis, oncology, and endocrine diseases primarily in the United States. The company has market cap of $1.56 billion. The Company’s product candidates include Abaloparatide-SC, an injectable subcutaneous formulation of abaloparatide, which has completed Phase III clinical trial for the treatment of patients with postmenopausal osteoporosis; and Abaloparatide-TD, a transdermal patch for use as a short wear-time transdermal patch. It currently has negative earnings. The firm is also involved in developing RAD1901, a selective estrogen receptor down-regulator/degrader, which is in Phase I clinical trial for the treatment of metastatic breast cancer, as well as in Phase IIb clinical trial for the treatment of postmenopausal vasomotor symptoms; and RAD140, a nonsteroidal selective androgen receptor modulator for the treatment of breast cancer.

Joshua Little, an insider and also director of the popular company Mercury General Corp made an investment. He obtained 500 shares of the firm with Joshua Little’s transaction worth near $21,338 US Dollars – based on an avg price of $42.7 per each share. For more details of this deal please read the D.C. based-SEC’s Form 4 available for free here. Joshua now has 500 shares accounting for 0.0009% of the Company’s market cap

The stock decreased 3.42% or $1.24 during the last trading session, reaching $34.95. About 402,710 shares traded. Radius Health, Inc. (RDUS) has risen 9.02% since February 8, 2017 and is uptrending. It has underperformed by 7.68% the S&P500.

Analysts await Radius Health, Inc. (NASDAQ:RDUS) to report earnings on February, 22. They expect $-1.49 earnings per share, down 22.13% or $0.27 from last year’s $-1.22 per share. After $-1.31 actual earnings per share reported by Radius Health, Inc. for the previous quarter, Wall Street now forecasts 13.74% negative EPS growth.

Since January 1, 0001, it had 5 insider purchases, and 0 insider sales for $12.33 million activity.

Mpm Asset Management Llc holds 73.13% of its portfolio in Radius Health, Inc. for 3.89 million shares. Bb Biotech Ag owns 5.50 million shares or 5.87% of their US portfolio. Moreover, Camber Capital Management Llc has 2.81% invested in the company for 1.15 million shares. The Maryland-based Rock Springs Capital Management Lp has invested 1.68% in the stock. Farallon Capital Management Llc, a California-based fund reported 3.94 million shares.

The stock decreased 0.06% or $0.025 during the last trading session, reaching $42.975. About 335,043 shares traded or 39.60% up from the average. Mercury General Corporation (NYSE:MCY) has risen 6.61% since February 8, 2017 and is uptrending. It has underperformed by 10.09% the S&P500.

Mercury General Corporation, together with its subsidiaries, engages in writing personal automobile insurance in the United States. The company has market cap of $2.38 billion. The firm also writes homeowners, commercial automobile, commercial property, mechanical breakdown, and umbrella insurance. It has a 16.41 P/E ratio. The Company’s automobile insurance products cover collision, property damage, bodily injury, comprehensive, personal injury protection, underinsured and uninsured motorist, and other hazards; and homeowner??s insurance products cover dwelling, liability, personal property, fire, and other hazards.

Investors sentiment increased to 1.51 in 2017 Q3. Its up 0.47, from 1.04 in 2017Q2. It is positive, as 4 investors sold Mercury General Corporation shares while 51 reduced holdings. 24 funds opened positions while 59 raised stakes. 25.16 million shares or 2.63% less from 25.84 million shares in 2017Q2 were reported. United Fin Advisers Lc reported 0% stake. 2.53M were reported by Vanguard Grp. Tower Research Cap Limited Liability Com (Trc) invested 0.01% of its portfolio in Mercury General Corporation (NYSE:MCY). Moreover, State Street has 0.01% invested in Mercury General Corporation (NYSE:MCY). Stifel Financial Corporation reported 0% in Mercury General Corporation (NYSE:MCY). Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Inv Mngmt Corporation reported 9,000 shares or 0% of all its holdings. Schwab Charles Mgmt invested in 253,164 shares or 0.01% of the stock. Ubs Asset Mgmt Americas stated it has 22,086 shares. Stephens Inc Ar holds 0.01% or 6,847 shares in its portfolio. Utah Retirement stated it has 0.01% of its portfolio in Mercury General Corporation (NYSE:MCY). Fincl Bank Of America De holds 31,646 shares or 0% of its portfolio. Semper Augustus Gp Ltd Liability Corporation has 64,792 shares. Moreover, Cap has 0.1% invested in Mercury General Corporation (NYSE:MCY) for 1.42M shares. Parametric Portfolio Assoc Ltd Liability Corporation, a Washington-based fund reported 62,081 shares. First Quadrant Lp Ca has 101 shares for 0% of their portfolio.

Among 2 analysts covering Mercury General (NYSE:MCY), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Mercury General had 3 analyst reports since August 26, 2015 according to SRatingsIntel. Raymond James upgraded the stock to “Mkt Perform” rating in Friday, February 19 report. Compass Point maintained it with “Neutral” rating and $55 target in Tuesday, May 3 report. The firm has “Sell” rating by Zacks given on Wednesday, August 26.